ES2196014T3 - Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes. - Google Patents
Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes.Info
- Publication number
- ES2196014T3 ES2196014T3 ES94107918T ES94107918T ES2196014T3 ES 2196014 T3 ES2196014 T3 ES 2196014T3 ES 94107918 T ES94107918 T ES 94107918T ES 94107918 T ES94107918 T ES 94107918T ES 2196014 T3 ES2196014 T3 ES 2196014T3
- Authority
- ES
- Spain
- Prior art keywords
- sparkling
- viruses
- preparation
- recombinant
- vometers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
- C12N2740/17022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
- C12N2740/17041—Use of virus, viral particle or viral elements as a vector
- C12N2740/17043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/80—Vectors comprising a special translation-regulating system from vertebrates
- C12N2840/85—Vectors comprising a special translation-regulating system from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA PREPARACION DE NUEVOS SISTEMAS DE VECTORES QUE SE GENERAN MEDIANTE UNA RECOMBINACION IN VITRO, UTILIZANDO TECNICAS GENETICAS, DE ACIDOS NUCLEICOS A PARTIR DE ESPECIES DE VIRUS ESPUMOSOS Y DE ACIDO NUCLEICO EXOGENO Y SE PRODUCEN MEDIANTE CELULAS HUESPEDES ADECUADAS O MEDIANTE LINEAS CELULARES DE FUSION ALTERADAS DE FORMA RECOMBINANTE. LA PREPARACION RECOMBINANTE DE LINEAS CELULARES DE FUSION PARTICULARMENTE ADECUADAS TAMBIEN FORMA PARTE DE ESTA INVENCION. LA INVENCION SE CARACTERIZA POR LA TRANSFERENCIA SEGURA Y EFICIENTE A TRAVES DE VECTORES DE VIRUS ESPUMOSOS DE GENES TERAPEUTICOS O DE CUALQUIER OTRO TIPO DE GENES EN CELULAS EUCARIOTICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4318387A DE4318387A1 (de) | 1993-06-03 | 1993-06-03 | Rekombinante Foamy Virus Vektoren für medizinische und diagnostische Anwendungen sowie Verfahren zur Herstellung von rekombinanten Foamy Virus Vektoren |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2196014T3 true ES2196014T3 (es) | 2003-12-16 |
Family
ID=6489499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94107918T Expired - Lifetime ES2196014T3 (es) | 1993-06-03 | 1994-05-24 | Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5646032A (es) |
EP (1) | EP0632129B1 (es) |
JP (2) | JPH06343477A (es) |
AT (1) | ATE237693T1 (es) |
CA (1) | CA2124769C (es) |
DE (2) | DE4318387A1 (es) |
DK (1) | DK0632129T3 (es) |
ES (1) | ES2196014T3 (es) |
PT (1) | PT632129E (es) |
SI (1) | SI0632129T1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2707091B1 (fr) | 1993-06-30 | 1997-04-04 | Cohen Haguenauer Odile | Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes. |
FR2727429B1 (fr) * | 1994-11-30 | 1997-11-28 | Haguenauer Odile Cohen | Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs |
DE19503082A1 (de) | 1995-02-01 | 1996-08-08 | Univ Ludwigs Albert | Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen |
US5888767A (en) * | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
CA2279673A1 (en) * | 1995-12-15 | 1997-06-16 | Enzo Therapeutics, Inc. | Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
US6492165B1 (en) | 1997-02-12 | 2002-12-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Retrovirus isolated from humans |
US5882912A (en) * | 1997-02-12 | 1999-03-16 | Center For Disease Control And Prevention | Retrovirus isolated from humans |
US5929222A (en) * | 1997-03-14 | 1999-07-27 | Transgene S.A. | Expression of a foamy virus envelope protein |
WO2000024876A2 (en) | 1998-10-27 | 2000-05-04 | The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services | Spumavirus isolated from humans |
DE19858441C2 (de) * | 1998-12-17 | 2001-02-15 | Deutsches Krebsforsch | FV-Vektoren zur Expression von Fremdgenen in Säugern und deren Verwendung |
WO2000041732A1 (en) * | 1999-01-19 | 2000-07-20 | The Children's Hospital Of Philadelphia | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
US6800475B1 (en) | 1999-06-14 | 2004-10-05 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation of a human retrovirus |
US20050244429A1 (en) * | 2002-06-27 | 2005-11-03 | Thomas Folks | Live replicating spumavirus vector |
US20080214437A1 (en) * | 2002-09-06 | 2008-09-04 | Mohapatra Shyam S | Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
AU2003268531A1 (en) | 2002-09-06 | 2004-03-29 | University Of South Florida | Materials and methods for treatment of allergic diseases |
US8071560B2 (en) * | 2004-02-17 | 2011-12-06 | University Of South Florida | Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor |
EP1727556A2 (en) * | 2004-02-17 | 2006-12-06 | University Of South Florida | Materials and methods for treatment of inflammatory and cell proliferation disorders |
EP1750748A1 (en) * | 2004-06-04 | 2007-02-14 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Use of the foamy virus bet protein for inactivating apobec |
US10184942B2 (en) | 2011-03-17 | 2019-01-22 | University Of South Florida | Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer |
CN111093715A (zh) * | 2017-09-18 | 2020-05-01 | 儿童医院医疗中心 | 强绝缘子和其在基因递送中的用途 |
-
1993
- 1993-06-03 DE DE4318387A patent/DE4318387A1/de not_active Withdrawn
-
1994
- 1994-05-24 SI SI9430447T patent/SI0632129T1/xx unknown
- 1994-05-24 AT AT94107918T patent/ATE237693T1/de not_active IP Right Cessation
- 1994-05-24 DE DE69432500T patent/DE69432500T2/de not_active Expired - Lifetime
- 1994-05-24 PT PT94107918T patent/PT632129E/pt unknown
- 1994-05-24 DK DK94107918T patent/DK0632129T3/da active
- 1994-05-24 EP EP94107918A patent/EP0632129B1/en not_active Expired - Lifetime
- 1994-05-24 ES ES94107918T patent/ES2196014T3/es not_active Expired - Lifetime
- 1994-05-30 JP JP6137880A patent/JPH06343477A/ja active Pending
- 1994-05-31 CA CA002124769A patent/CA2124769C/en not_active Expired - Fee Related
- 1994-11-28 US US08/345,278 patent/US5646032A/en not_active Expired - Lifetime
-
2006
- 2006-12-20 JP JP2006343352A patent/JP2007082562A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE4318387A1 (de) | 1994-12-08 |
ATE237693T1 (de) | 2003-05-15 |
JP2007082562A (ja) | 2007-04-05 |
DK0632129T3 (da) | 2003-08-04 |
CA2124769A1 (en) | 1994-12-04 |
EP0632129A1 (en) | 1995-01-04 |
PT632129E (pt) | 2003-08-29 |
EP0632129B1 (en) | 2003-04-16 |
CA2124769C (en) | 2007-07-10 |
JPH06343477A (ja) | 1994-12-20 |
DE69432500T2 (de) | 2003-11-20 |
SI0632129T1 (en) | 2003-08-31 |
DE69432500D1 (de) | 2003-05-22 |
US5646032A (en) | 1997-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2196014T3 (es) | Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes. | |
ATE79649T1 (de) | Herpes simplex-virus als vektor. | |
EE05138B1 (et) | Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin | |
Ramsay et al. | DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors | |
WO1995006743A3 (en) | Methods and compositions for the large scale production of recombinant adeno-associated virus | |
CY1106513T1 (el) | Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna | |
CA2072627A1 (en) | Recombinant herpes simplex viruses vaccines and methods | |
CA2104396A1 (en) | Viral particles having altered host range | |
DK0784693T3 (da) | Virusvektorer til genterapi | |
AU8067698A (en) | Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus | |
ATE284954T1 (de) | Hyaluronan synthase gen und seine verwendung | |
CA2321964A1 (en) | Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus | |
EP0261940A3 (en) | Pseudorabies vaccines and dna vectors for recombination with pox viruses | |
HUT67962A (en) | Microsomal triglyceride transfer protein | |
WO1998055639A3 (fr) | Vecteurs adenoviraux recombinants comprenant une sequence d'epissage | |
KR0181976B1 (ko) | 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학 분야에서 이들을 사용하는 방법 | |
EP2044950A3 (en) | Attenuated VIF DNA immunization cassettes for genetic vaccines | |
WO1994013812A3 (en) | Novel entomopoxvirus genes, proteins and methods of use thereof | |
DK0843731T3 (da) | Adenovirusvektorer til genterapi | |
NO922728L (no) | Vaksine mot coccidiose | |
AU4334193A (en) | Infectious bovine rhinotracheitis virus mutants and vaccines | |
DK498387A (da) | Virus-dna-sekvens | |
ATE227775T1 (de) | Impfstoff-vektoren von rekombinantem katzen- herpesvirus | |
BR9806084A (pt) | Vetor de poliovirus sabin tipo i, recombinante ou quimérico de replicação competente, seus métodos de produção e célula hospedeira | |
WO1992014818A3 (en) | Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |